Kebuzone
Clinical data | |
---|---|
Routes of administration | intramuscular |
ATC code |
|
Pharmacokinetic data | |
Elimination half-life | 70–100 hours |
Excretion | renal |
Identifiers | |
| |
CAS Number |
|
PubChem CID |
|
DrugBank |
|
ChemSpider |
|
UNII |
|
KEGG |
|
ChEBI |
|
CompTox Dashboard (EPA) |
|
ECHA InfoCard | 100.011.560 |
Chemical and physical data | |
Formula | C19H18N2O3 |
Molar mass | 322.364 g·mol−1 |
3D model (JSmol) |
|
| |
| |
(what is this?) (verify) |
Kebuzone (or ketophenylbutazone) is a nonsteroidal anti-inflammatory drug (NSAID) that is used for the treatment of inflammatory conditions such as thrombophlebitis and rheumatoid arthritis (RA).[1][2][3]
References
- ^ Austria-Codex (in German). Vienna: Österreichischer Apothekerverlag. 2018. Rheumesser 3 ml-Ampullen.
- ^ "KEBUZONE". NCATS Inxight: Drugs. Retrieved 2019-02-27.
- ^ Aronson JK (2016). "Kebuzone". Meyler's Side Effects of Drugs: The International Encyclopedia of Adverse Drug Reactions and Interactions (Sixteenth ed.). Amsterdam. p. 405. ISBN 978-0-444-53716-4.
{{cite book}}
: CS1 maint: location missing publisher (link)